Compare DY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DY | RGEN |
|---|---|---|
| Founded | 1969 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.0B |
| IPO Year | 1995 | 1995 |
| Metric | DY | RGEN |
|---|---|---|
| Price | $273.80 | $190.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $425.30 | $167.67 |
| AVG Volume (30 Days) | 617.4K | ★ 882.0K |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.71 | ★ 286.96 |
| EPS | ★ 6.81 | 0.24 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $30.96 | $14.30 |
| Revenue Next Year | $9.49 | $14.52 |
| P/E Ratio | ★ $39.96 | $794.38 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $271.87 | $100.99 |
| 52 Week High | $566.47 | $192.49 |
| Indicator | DY | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 30.72 | 68.29 |
| Support Level | N/A | $158.15 |
| Resistance Level | $309.48 | N/A |
| Average True Range (ATR) | 10.92 | 6.10 |
| MACD | 2.31 | 1.44 |
| Stochastic Oscillator | 8.10 | 93.48 |
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.